Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.
1/5 보강
[This corrects the article DOI: 10.3389/fimmu.2025.1693755.].
APA
Zou L, Chen J, et al. (2025). Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.. Frontiers in immunology, 16, 1772783. https://doi.org/10.3389/fimmu.2025.1772783
MLA
Zou L, et al.. "Correction: Tumor-penetrating peptide boosts bispecific T-cell engager antitumor efficacy for the pancreatic cancer.." Frontiers in immunology, vol. 16, 2025, pp. 1772783.
PMID
41573566
Abstract
[This corrects the article DOI: 10.3389/fimmu.2025.1693755.].
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (5)
- Biomarkers for oesophageal squamous cell carcinoma and the role of HPV: Multi‑omics approaches and current evidence (Review).
- Advances in non-invasive delivery strategies for anti-cancer therapy.
- Validation of the BEST-J score and identification of bile reflux as a risk factor for delayed bleeding after gastric endoscopic submucosal dissection.
- Chidamide combined with fulvestrant in the treatment of HR-positive, HER2-negative advanced breast cancer after failure of previous endocrine therapy: a single-arm, single-center, phase 2 study.
- Segment Like A Doctor: Learning reliable clinical thinking and experience for pancreas and pancreatic cancer segmentation.